The Company has approved the unaudited Standalone financial results for the half year ended on September 30, 2025 along with the limited review report
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Broach Lifecare Hospital, a Gujarat-based hospital operator listed on BSE SME, reported unaudited H1 FY26 (April–September 2025) results with revenue from operations of ₹260.42 lakhs, up about 44% from ₹180.84 lakhs in H1 FY25. However, profit after tax fell to ₹31.21 lakhs from ₹44.19 lakhs (a drop of around 29%), pulling EPS down to ₹1.03 from ₹1.70. Total expenses surged sharply to ₹222.65 lakhs (vs ₹121.90 lakhs), driven mainly by higher other expenses, employee costs and purchases, which squeezed operating margins significantly. The statutory auditor issued a clean (unqualified) limited review report, and the board approved the results on November 14, 2025.
Top-line growth is encouraging, but the sharp fall in profits and negative operating cash flow of around ₹157 lakhs signal cost pressure and working-capital strain — near-term shareholder sentiment may be cautious despite the healthy revenue expansion.